Literature DB >> 31896301

Update on covered endovascular reconstruction of the aortic bifurcation.

Michel Mpj Reijnen1.   

Abstract

OBJECTIVE: The covered endovascular reconstruction of the aortic bifurcation (CERAB) technique was introduced in 2009 in order to provide an anatomically and physiologically optimal endovascular reconstruction of the aortic bifurcation.
METHOD: In the current review, all available evidence on this technique was summarized.
RESULTS: In vitro studies have shown a more favorable geometry of CERAB compared to kissing stents, leading to better local flow conditions. The results of CERAB are at least as good as those achieved with kissing stents in a more complex group of treated patients. The mid-term patency rates approach those of surgical reconstruction. Initial data show that the technique can also be used in combination with chimney grafts in order to preserve side branches.
CONCLUSION: CERAB has proven to be the most optimal endovascular treatment option for aorto-iliac occlusive disease with regard to geometry and flow and is related to promising clinical outcomes. Prospective and comparative trials are necessary to elucidate the most optimal treatment algorithm for patients with aorto-iliac occlusive disease.

Keywords:  Aortoiliac; Leriche syndrome; aortic bifurcation, CERAB; covered balloon-expandable stent; covered endovascular reconstruction of the aortic bifurcation; endovascular; iliac artery; occlusive disease

Mesh:

Year:  2020        PMID: 31896301     DOI: 10.1177/1708538119896197

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  2 in total

Review 1.  [Covered endovascular reconstruction of aortic bifurcation (CERAB)].

Authors:  Christoph G Radosa; C Reeps; H Nebelung; F Schön; R T Hoffmann
Journal:  Radiologie (Heidelb)       Date:  2022-03-29

2.  Leriche Syndrome with Digital Gangrene: Is Aortic Bypass Grafting Safe in Intravenous Drug Abusers? A Case Report and Literature Review.

Authors:  Syed Muhammad Hammad Ali; Ossama Ather; Aasim Malik
Journal:  Vasc Specialist Int       Date:  2022-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.